Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN5 | P54829 | 1/20 | 0.38 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.36 |
| ▸ | GABRG2 | P18507 | 4/20 | 0.34 |
| ▸ | GABRB3 | P28472 | 4/20 | 0.34 |
| ▸ | GABRA5 | P31644 | 4/20 | 0.34 |
| ▸ | GABRA3 | P34903 | 4/20 | 0.34 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.34 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.34 |
| ▸ | IDO1 | P14902 | 2/20 | 0.33 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.33 |
| ▸ | MAT2A | P31153 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.33 |
| ▸ | SYK | P43405 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1951237 | 0.85 | KIF11 (0.43) | PTPN5PGRPDK2 | |
| SCHEMBL1948721 | 0.78 | ENPP1 (0.38) | PTPN5CLK4PDK2TGFBR1ENPP1 | |
| SCHEMBL1949088 | 0.78 | ENPP1 (0.38) | PTPN5CLK4PDK2GABRG2GABRB3 | |
| SCHEMBL1949835 | 0.78 | PTPN5 (0.37) | PTPN5CLK4PDK2GABRG2GABRB3 | |
| SCHEMBL1948112 | 0.78 | PTPN5 (0.37) | PTPN5CLK4PDK2TGFBR1ENPP1 | |
| SCHEMBL1949350 | 0.77 | PTPN5 (0.36) | PTPN5CLK4PGRPDK2TGFBR1 | |
| SCHEMBL1948571 | 0.76 | MAT2A (0.36) | PTPN5CLK4PGRPDK2TGFBR1 | |
| SCHEMBL1948131 | 0.76 | ENPP1 (0.39) | PTPN5CLK4PDK2TGFBR1ENPP1 | |
| SCHEMBL1950429 | 0.75 | AR (0.37) | PTPN5PGRPDK2GABRG2GABRB3 | |
| SCHEMBL1947933 | 0.73 | PTPN5 (0.35) | PTPN5CLK4PDK2TGFBR1ENPP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9084420-B2 | Amide derivative, pest control agent containing the amide derivative, and pest controlling method | MITSUI CHEMICALS AGRO, INC. (JP) | 2015-07-21 | — | — | US | disclosed |
| US-20140107368-A1 | AMIDE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE AMIDE DERIVATIVE, AND PEST CONTROLLING METHOD | MITSUI CHEMICALS AGRO, INC. (JP) | 2014-04-17 | — | — | US | disclosed |
| US-8633228-B2 | Amide derivative, pest control agent containing the amide derivative, and pest controlling method | MITSUI CHEMICALS AGRO, INC. (JP) | 2014-01-21 | — | — | US | disclosed |
| US-20110136878-A1 | AMIDE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE AMIDE DERIVATIVE, AND PEST CONTROLLING METHOD | Mitsui Chemicals Agro., Inc. (JP) | 2011-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110136878-A1 | AMIDE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE AMIDE DERIVATIVE, AND PEST CONTROLLING METHOD | L3MBTL1, L3MBTL4, L3MBTL3 | PTPN5 1167/4885CLK4 390/4885PGR 4222/4885 |
| US-20140107368-A1 | AMIDE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE AMIDE DERIVATIVE, AND PEST CONTROLLING METHOD | L3MBTL1, L3MBTL4, L3MBTL3 | PTPN5 1167/4885CLK4 390/4885PGR 4222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.